Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

On Ozempic or Mounjaro? Nutrition Tips to Manage Appetite and Weight Changes

Lots of people are starting drugs like Ozempic and Mounjaro to lose weight or manage diabetes, and this story explains what that means for how you eat. The article is a practical guide about nutrition after you begin a GLP-1 drug — a class of medicines that change appetite and digestion. It’s not a clinical trial; it’s advice drawn from experts and existing research to help people adjust their diet while on these medications. GLP-1 drugs are medicines that copy a natural hormone in your gut called glucagon-like peptide-1. That hormone helps control blood sugar and tells your brain you are full. Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) act like that hormone so you feel less hungry, get full faster, and your stomach empties more slowly. They don’t “melt fat” directly; they change signals about hunger and fullness and can lower the amount you eat. The practical advice in the article comes from nutritionists and researchers who’ve worked with people taking these drugs. They report common effects: reduced appetite, changes in taste or food preferences, and sometimes nausea or trouble tolerating certain foods. That means portions often shrink and people may skip meals unintentionally, so the guidance focuses on making meals nutrient-dense — preserving protein, fiber, vitamins and minerals even if you’re eating less. Recommendations include prioritizing protein at each meal to protect muscle, choosing whole foods with fiber for satiety, and using smaller, more frequent meals or liquid calories if solid food is hard to keep down. This matters because losing weight quickly or eating much less can unintentionally cause nutrient shortfalls or muscle loss. For people on these drugs — whether for diabetes or weight management — the goal should be healthful weight loss: keep protein intake up, get enough iron, calcium and other key nutrients, and avoid relying on ultra-processed convenience foods that are high in calories but low in nutrition. People with diabetes also need to monitor blood sugar changes and medication doses; eating less can change insulin needs, so doctors should be kept in the loop. There are important cautions. These drugs can cause nausea, vomiting, constipation or diarrhea for some people, which affects what you can eat. If you have a history of pancreatitis, certain thyroid cancers, or are pregnant or breastfeeding, these medicines may be unsafe — check with a clinician. Also, because advice in the article comes from experts and observational experience rather than a single large randomized trial of specific diets on GLP-1 drugs, some recommendations are best-practice rather than proven formulas. Always talk with your prescribing clinician and, if possible, a registered dietitian who understands these medications. Bottom line: GLP-1 drugs change appetite and digestion, so plan meals to be smaller but more nutrient-packed, prioritize protein and fiber, watch for side effects, and keep your healthcare team informed.

Source: The Conversation

Read full story

Back to Riding the pepTIDE